Edit Symbol List
Don't know the stock symbol? Use the
Symbol Lookup tool.
Alphabetize the sort order of my symbols
Investing just got easier…
ETFs with BMY as a Top 10 Holding*
|Weighting||ETF Name (Symbol)||100-Day Price Change (%)|
|6.72%||iShares U.S. Pharmaceutical ETF (IHE)||-22.55 (-13.76%)|
|5.15%||PowerShares Dynamic Pharmaceuticals (PJP)||-9.00 (-12.63%)|
|5.01%||Columbia Select Large Cap Growth ETF (RWG)||-10.12 (-20.65%)|
|4.85%||VanEck Vectors Pharmaceutical ETF (PPH)||-9.00 (-13.60%)|
|4.14%||SPDR Select Sector Fund - Health Care (XLV)||-3.58 (-4.90%)|
Company Description (as filed with the SEC)
Bristol-Myers Squibb Company (which may be referred to as Bristol-Myers Squibb, BMS, the Company, we, our or us) was incorporated under the laws of the State of Delaware in August 1933 under the name Bristol-Myers Company, as successor to a New York business started in 1887. In 1989, Bristol-Myers Company changed its name to Bristol-Myers Squibb Company as a result of a merger. We are engaged in the discovery, development, licensing, manufacturing, marketing, distribution and sale of biopharmaceutical products on a global basis. We operate in one segment--BioPharmaceuticals. For additional information about business segments, refer to "Item 8. Financial Statements--Note 2. Business Segment Information." We compete with other worldwide research-based drug companies, smaller research companies and generic drug manufacturers. Our products are sold worldwide, primarily to wholesalers, retail pharmacies, hospitals, government entities and the medical profession. ... More ...
Where does BMY fit in the risk graph?
|Annual EPS Est:||$2.01|
|Quarterly EPS Est:||0.64|